2013 glutathione parkinson's disease four authors Potential use of as a treatment for Parkinson's disease - The Lancet

Multiple observational studies have found that individuals with low B12 are significantly more likely to report depressive symptoms, and intervention studies show that correcting the deficiency improves mood outcomes sometimes substantially

THNH PHN 2

Continue Ta1 for an additional 4 weeks for lasting immune rebalancing Expected timeline: Week 1 to 2: Gradual reduction in baseline inflammation Week 3 to 4: Noticeable decrease in reactivity to allergens During season: Reduced sneezing, congestion, and eye symptoms compared to previous years Monitoring: Track symptom scores daily using a standardized allergy symptom diary

48 week cycle is optimal